Aeglea BioTherapeutics Inc

-0.03 (-5.82%)
Debt Financing / Related, Restructuring / Reorganization

Aeglea Biotherapeutics Announces Leadership Transition And Corporate Restructuring

Published: 08/24/2022 12:12 GMT
Aeglea BioTherapeutics Inc (AGLE) - Aeglea Biotherapeutics Announces Leadership Transition and Corporate Restructuring.
Aeglea Bio Therapeutics Inc- Corporate Restructuring to Extend Runway Into Q4 2023.
Aeglea Bio Therapeutics Inc- Restructuring Has Further Reduced Headcount of Company Resulting in an Approximately 25% Reduction Year-to-date.
Aeglea Bio Therapeutics Inc- Anthony Quinn, President, CEO and Board Memberstepped Down From His Current Positions and Transitioned to an Advisory Role.
Aeglea Bio Therapeutics Inc- Prioritizing Resources and Focus on Agle-177 and Completion of Ongoing Phase 1/2 Trial in Homocystinuria.